ÂÜÀòÂÒÂ×

Laura Christian Resly, Ph.D., is currently a Scientist II at Precision BioSciences, Inc., where work focuses on advancing the understanding of ARCUS technologies and leading projects on allogeneic CAR T cells targeting solid tumors. Prior experience includes serving as a Scientist I at Duke University, where Laura completed a Ph.D. in Immunology, and holding research roles at UCSF and UC San Diego, involving significant contributions to immunological studies and clinical trials. Educational qualifications include a BS in Biochemistry and Cell Biology from UC San Diego and a Ph.D. in Immunology from Duke University.